Prostate-specific membrane antigen radioguided surgery: a promising utility

BJU Int. 2017 Jul;120(1):5-6. doi: 10.1111/bju.13838.

Authors

Nicolas Geurts^{1

2}, Alastair D Lamb^{1

2}, Nathan Lawrentschuk^{1

2

3}, Declan G Murphy^{1

4

5}

Affiliations

¹ Division of Cancer Surgery, University of Melbourne, Melbourne, Vic., Australia.
² Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
³ Department of Surgery, Austin Hospital, University of Melbourne, Heidelberg, Vic., Australia.
⁴ Australian Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, Vic., Australia.
⁵ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia.

PMID: 28621060
DOI: 10.1111/bju.13838

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antigens, Surface*
Glutamate Carboxypeptidase II*
Humans
Male
Prostate-Specific Antigen
Radiopharmaceuticals

Substances

Antigens, Surface
Radiopharmaceuticals
FOLH1 protein, human
Glutamate Carboxypeptidase II
Prostate-Specific Antigen